Crossref
A NEW HYPERFRACTIONATION EFFECT IN THEPHARMACOKINETICS OF DOPAMINERGIC AGONIST(CABERGOLINE) FOR THE LONG-TERM TREATMENT OFNON-FUNCTIONING PITUITARY TUMOURS
Acta Endocrinologica (Bucharest) · 2005
DOI: 10.4183/aeb.2005.121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Endocrinologica (Bucharest), 2005. Verfasst von Gabriel Burstein.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Burstein, G. (2005). A NEW HYPERFRACTIONATION EFFECT IN THEPHARMACOKINETICS OF DOPAMINERGIC AGONIST(CABERGOLINE) FOR THE LONG-TERM TREATMENT OFNON-FUNCTIONING PITUITARY TUMOURS. Acta Endocrinologica (Bucharest). https://doi.org/10.4183/aeb.2005.121
Vancouver
Burstein G. A NEW HYPERFRACTIONATION EFFECT IN THEPHARMACOKINETICS OF DOPAMINERGIC AGONIST(CABERGOLINE) FOR THE LONG-TERM TREATMENT OFNON-FUNCTIONING PITUITARY TUMOURS. Acta Endocrinologica (Bucharest). 2005. doi:10.4183/aeb.2005.121
BibTeX
@article{Burstein2005,
author = {Burstein, Gabriel},
title = {A NEW HYPERFRACTIONATION EFFECT IN THEPHARMACOKINETICS OF DOPAMINERGIC AGONIST(CABERGOLINE) FOR THE LONG-TERM TREATMENT OFNON-FUNCTIONING PITUITARY TUMOURS},
journal = {Acta Endocrinologica (Bucharest)},
year = {2005},
doi = {10.4183/aeb.2005.121}
}
EUVIMED